FTC demands Boston Scientific divest business amid $4.2bn deal
08-08-2019
NicoElnino / iStockphoto.com
Medical device manufacturer Boston Scientific today announced that it will acquire UK-based healthcare company BTG for $4.2 billion.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Boston Scientific, mergers & acquisitions, medical device manufacture, commercialisation, cancer, IP portfolio, healthcare, pulmonary embolism
